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Proposal
We need a faster and more efficient way of improving
patient outcomes in all disease areas. There is a need
for a cultural shift in randomised phase III superiority
trials. We propose there be fewer two-arm trials and
more trials that incorporate multiple research arms.
Setting
Well-designed, well-conducted randomised controlled
trials (RCTs) are the most reliable way to collect com-
parative evidence on efficacy and effectiveness, and drive
changes in policy and healthcare. A literature search has
shown that ~80% of all trials have only 2 arms. A key
problem is their low success rate, defined as a convin-
cing finding that the research treatment is better than
the current standard-of-care. New treatments commonly
do not work as well as hoped, yet we persist with tradi-
tional phase III RCTs, that are both expensive and often
take many years. A direct conclusion from the high fail-
ure rate is that the information on which phase III trials
are designed must be flawed. In planning any 2-arm
phase III trial, fundamental uncertainties often remain;
for example, whether we have reliably selected the most
appropriate dose and/or duration of treatment or, for
the academic community, whether other treatments
have equal (or greater) priority for being assessed?
Conclusion
An academic RCT should not be seen as a way of asses-
sing a specific treatment, but considered as a central
tool to improving outcomes for patients with a particu-
lar condition as quickly as possible. Therefore, we argue
that many more trials should have more than one
research arm.
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